Lucid Diagnostics Stock Forecast - Accumulation Distribution
| LUCD Stock | USD 1.21 0.14 13.08% |
Lucid Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Lucid Diagnostics stock prices and determine the direction of Lucid Diagnostics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Lucid Diagnostics' historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time the relative strength index (rsi) of Lucid Diagnostics' share price is below 20 . This indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.09) | EPS Estimate Current Year (0.43) | EPS Estimate Next Year (0.30) | Wall Street Target Price 3.7917 | EPS Estimate Current Quarter (0.09) |
Using Lucid Diagnostics hype-based prediction, you can estimate the value of Lucid Diagnostics from the perspective of Lucid Diagnostics response to recently generated media hype and the effects of current headlines on its competitors.
Lucid Diagnostics after-hype prediction price | USD 1.21 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Lucid Diagnostics to cross-verify your projections. Lucid Diagnostics Additional Predictive Modules
Most predictive techniques to examine Lucid price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Lucid using various technical indicators. When you analyze Lucid charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 329481.0 | 0.13 |
| Check Lucid Diagnostics Volatility | Backtest Lucid Diagnostics | Information Ratio |
Lucid Diagnostics Trading Date Momentum
| On January 25 2026 Lucid Diagnostics was traded for 1.21 at the closing time. The top price for the day was 1.23 and the lowest listed price was 1.07 . There was no trading activity during the period 0.0. Lack of trading volume on January 25, 2026 did not cause price change. The trading delta at closing time against the current closing price is 11.57% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Lucid Diagnostics to competition |
Other Forecasting Options for Lucid Diagnostics
For every potential investor in Lucid, whether a beginner or expert, Lucid Diagnostics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Lucid Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Lucid. Basic forecasting techniques help filter out the noise by identifying Lucid Diagnostics' price trends.Lucid Diagnostics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Lucid Diagnostics stock to make a market-neutral strategy. Peer analysis of Lucid Diagnostics could also be used in its relative valuation, which is a method of valuing Lucid Diagnostics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Lucid Diagnostics Market Strength Events
Market strength indicators help investors to evaluate how Lucid Diagnostics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Lucid Diagnostics shares will generate the highest return on investment. By undertsting and applying Lucid Diagnostics stock market strength indicators, traders can identify Lucid Diagnostics entry and exit signals to maximize returns.
Lucid Diagnostics Risk Indicators
The analysis of Lucid Diagnostics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Lucid Diagnostics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting lucid stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.37 | |||
| Semi Deviation | 2.89 | |||
| Standard Deviation | 3.31 | |||
| Variance | 10.96 | |||
| Downside Variance | 11.92 | |||
| Semi Variance | 8.37 | |||
| Expected Short fall | (2.80) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Lucid Diagnostics
The number of cover stories for Lucid Diagnostics depends on current market conditions and Lucid Diagnostics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Lucid Diagnostics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Lucid Diagnostics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Lucid Diagnostics Short Properties
Lucid Diagnostics' future price predictability will typically decrease when Lucid Diagnostics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Lucid Diagnostics often depends not only on the future outlook of the potential Lucid Diagnostics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Lucid Diagnostics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 50.5 M | |
| Cash And Short Term Investments | 22.4 M |
Check out Historical Fundamental Analysis of Lucid Diagnostics to cross-verify your projections. For information on how to trade Lucid Stock refer to our How to Trade Lucid Stock guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lucid Diagnostics. If investors know Lucid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lucid Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.77) | Revenue Per Share | Quarterly Revenue Growth 0.033 | Return On Assets | Return On Equity |
The market value of Lucid Diagnostics is measured differently than its book value, which is the value of Lucid that is recorded on the company's balance sheet. Investors also form their own opinion of Lucid Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Lucid Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lucid Diagnostics' market value can be influenced by many factors that don't directly affect Lucid Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lucid Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Lucid Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lucid Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.